Table 2.
NTA | TA | |
---|---|---|
No. cores | 23 | 24 |
Mean age | 61.7 | 62.3 |
Mean PSA (ng/ml) | 4.5 | 6.6 |
Gleason: | ||
6 | — | 14 |
7 | — | 9 |
8 | — | 1 |
Clinical stage: | ||
T1c | — | 6 |
T2 | — | 2 |
T2a | — | 2 |
T2b | — | 4 |
T2c | — | 4 |
T3a | — | 1 |
T3b | — | 1 |
T4 | — | 1 |
Unknown | — | 3 |
NTA | TA | |
---|---|---|
No. cores | 23 | 24 |
Mean age | 61.7 | 62.3 |
Mean PSA (ng/ml) | 4.5 | 6.6 |
Gleason: | ||
6 | — | 14 |
7 | — | 9 |
8 | — | 1 |
Clinical stage: | ||
T1c | — | 6 |
T2 | — | 2 |
T2a | — | 2 |
T2b | — | 4 |
T2c | — | 4 |
T3a | — | 1 |
T3b | — | 1 |
T4 | — | 1 |
Unknown | — | 3 |